ResearcherThe University of MelbourneActive in the last 2 years
Yi Ma
Matched on ORCID iD 0000-0003-2351-9537; OpenAlex author ID A5076351207. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 3 papers · 2026: 2 papers
Papers 8
- A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of Pancreatic Cancer. Co-author DOI 10.1002/cam4.71535↗
- The interplay between p21-activated kinases and tumour-infiltrating dendritic cells and T cells and its implication in pancreatic cancer immunotherapy. First author DOI 10.1186/s12964-026-02923-y↗
- Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an Autophagy-Independent Pathway. Co-author DOI 10.3390/cancers17030511↗
- The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. Co-author DOI 10.3390/cancers17213434↗
- P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisation. Co-author DOI 10.3390/ijms26178357↗
- Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity. Co-author DOI 10.1186/s12964-024-01670-2↗
- CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stroma. First author PMID 37193135↗
- The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2022.215868↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mehrdad Nikfarjam · 8 shared papers, 2022–2026 · strength 2.33
- Paper The interplay between p21-activated kinases and tumour-infiltrating dendritic cells and T cells and its implication in … DOI 10.1186/s12964-026-02923-y↗
- Paper A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of … DOI 10.1002/cam4.71535↗
- Paper Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an Autophagy-Independent … DOI 10.3390/cancers17030511↗
- Hong Zhen He · 6 shared papers, 2022–2026 · strength 1.67
- Paper A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of … DOI 10.1002/cam4.71535↗
- Paper Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an Autophagy-Independent … DOI 10.3390/cancers17030511↗
- Paper The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. DOI 10.3390/cancers17213434↗
- Ching‐Seng Ang · 5 shared papers, 2023–2025 · strength 1.25
- Paper Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an Autophagy-Independent … DOI 10.3390/cancers17030511↗
- Paper The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. DOI 10.3390/cancers17213434↗
- Paper P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisati… DOI 10.3390/ijms26178357↗
- Arian Ansardamavandi · 2 shared papers, 2025 · strength 0.54
- Hong He · 1 shared paper, 2026 · strength 0.43
- Rui Jian · 1 shared paper, 2026 · strength 0.43
- Hong He · 1 shared paper, 2024 · strength 0.23
- Kai Wang · 1 shared paper, 2023 · strength 0.18
- Nien‐Hung Lee · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.